China NMPA Drug Inspection - Harbin No. 6 Pharmaceutical Factory Co., Ltd. - Acanthopanax senticosus granules
China NMPA drug inspection for Harbin No. 6 Pharmaceutical Factory Co., Ltd. published June 22, 2018. Drug: Acanthopanax senticosus granules. On June 22, 2018, the National Medical Products Administration (NMPA) of China issued an announcement detailing the non-
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Harbin No. 6 Pharmaceutical Factory Co., Ltd. published June 22, 2018. Drug: Acanthopanax senticosus granules. On June 22, 2018, the National Medical Products Administration (NMPA) of China issued an announcement detailing the non-
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox